跳至主要内容
临床试验/JPRN-UMIN000001608
JPRN-UMIN000001608已完成未知

Establishment of surveillance system for the longstanding ulcerative colitis patients Comparative study of efficacy for the targeted biopsy and the step biopsy - Establishment of surveillance system for the longstanding ulcerative colitis patients

Teikyo University School of Medicine0 个研究点目标入组 200 人开始时间: 2009年1月5日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Patients who have past history of colon cancer and/or ulcerative colitis associated neoplasm 2) Patients suspected of bleeding diathesis or coagulation abnormality 3) Renal dysfunction (Cre > 1.2 mg/dl) 4)Pregnancy or breast feeding 5)Otherwise, patiesnts who investigator judged ineligible to register

研究者

发起方
Teikyo University School of Medicine

相似试验

已完成
不适用
Establishment of the surveillance system exploring risk factors for emergency transportation outside a remote island.chronic illness, osteoporosis, and patients with potentially high risk for emergency admissions.
JPRN-UMIN000033313The Institute of Medical Science, the University of Tokyo2,000
尚未招募
不适用
Establishment of surveillance system for individuals diagnosed with COVID-19.
CTRI/2020/08/027078Tata Memorial Hospital
招募中
不适用
A prospective registry for the surveillance to improve the management of coronary artery disease: Juntendo Physicians Alliance for Clinical Trials (J-PACT) PCI database.Coronary artery disease
JPRN-UMIN000035587Juntendo University, Graduate School of Medicine Department of Cardiovascular Biology and Medicine10,000
进行中(未招募)
1 期
A research study to collect long term safety information from subjects who have received study treatment from a qualifying lenabasum Corbus trial.Dermatomyositis (DM) is a rare and serious autoimmune disease.An overactive immune response causes chronic inflammation,which results in growth of scar tissue in the skin,muscles,and many internal organs.Cystic Fibrosis (CF) is a genetic disorder which results in thick mucus formation on the airways leading to increased lung infections,fibrosis of the lungs and digestive tract and abnormal immune functionMedDRA version: 20.0Level: PTClassification code 10012503Term: DermatomyositisSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersMedDRA version: 20.0Level: PTClassification code 10011762Term: Cystic fibrosisSystem Organ Class: 10010331 - Congenital, familial and genetic disorders
EUCTR2020-001762-11-HUCorbus Pharmaceuticals, Inc.100
进行中(未招募)
1 期
A research study to collect long term safety information from subjects who have received study treatment from a qualifying lenabasum Corbus trial.
EUCTR2020-001762-11-GBCorbus Pharmaceuticals, Inc.100